Sharon Jackson

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Serum 25-Hydroxyvitamin D ₃ Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma

Julia Newton‐Bishop, Samantha Beswick, Juliette A. Randerson‐Moor et al. · Journal of Clinical Oncology · 2009 · 282 citations · Full text

Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism

Clive Kearon, Jeffrey S. Ginsberg, Jim A. Julian et al. · JAMA · 2006 · 256 citations

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

William G. Wierda, John N. Allan, Tanya Siddiqi et al. · Journal of Clinical Oncology · 2021 · 217 citations · Full text

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Constantine S. Tam, John N. Allan, Tanya Siddiqi et al. · Blood · 2022 · 216 citations · Full text

Primary Endpoint, Pathology, First-line Treatment +19